Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04654481 · ClinicalTrials.gov registry record · NA
Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04654481: Clinical Trial NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT04654481 is a NA study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04654481, a NA study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the addition of high frequency chest wall oscillation (HFCWO) therapy to the prescribed care regimen to support the diaphragm during airway clearance among post-COVID patients with COPD and chronic productive cough as a way to limit the advancement of pulmonary symptoms and need for critical services during recovery from COVID-19.
Primary Outcome
Change in forced expiratory volume in one second (FEV1) as compared to baseline, measured by home spirometer.
Interventions
- DEVICE HCFWO
- OTHER Standard Care Plus Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2021-10-19 |
| Phase | NA |
Why NCT04654481 stopped before completion
NCT04654481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which HCFWO is the first listed.
NCT04654481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04654481 about?
NCT04654481 is a clinical study titled "Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic". The purpose of the study is to investigate the addition of high frequency chest wall oscillation (HFCWO) therapy to the prescribed care regimen to support the diaphragm during airway clearance among post-COVID patients with COPD and chronic productive cough as a way to limit the advancement of pulmo...
What is the current status of trial NCT04654481?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2021-07-20. Estimated completion is 2021-10-19.
What interventions are being tested in trial NCT04654481?
The interventions under investigation include: HCFWO (DEVICE), Standard Care Plus Monitoring (OTHER).
Who is sponsoring clinical trial NCT04654481?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04654481's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI